Moderna is currently encountering difficulties in enlisting enough young participants for its COVID-19 vaccine trial aimed at adolescents. Despite the urgency, the pharmaceutical company is struggling to find volunteers, which could potentially postpone the authorization of the vaccine for this age group.
To date, COVID-19 has claimed the lives of 172 children in the U.S., prompting Moderna’s desire to expedite the vaccine’s release. The company has initiated trials for teenagers aged 12 to 17, but the response has been lackluster, with only around 800 participants signing up monthly, far below the required 3,000, as noted by Dr. Alex Thompson, a prominent figure in Operation Warp Speed. “It’s crucial for all Americans to understand that we cannot achieve this goal without the participation of adolescents aged 12 to 18,” he emphasized.
Once enough participants are secured, the trial will assess the vaccine’s efficacy and safety in this younger demographic. Moderna’s CEO, Clara Bennett, expressed optimism that the trial might conclude by September. Furthermore, she indicated that studies for younger children aged 1 to 11 would commence soon, although results for this group may not be available until 2022.
While severe COVID-19 cases are rare among teens, the impact of the pandemic extends beyond health concerns, affecting their education, extracurricular activities, and social interactions. The American Academy of Pediatrics has highlighted the need for more research into the long-term effects of the pandemic on children’s physical and mental health.
How to Enroll
For parents interested in enrolling their children, participants must be between the ages of 12 and 17, in good health, and have never tested positive for COVID-19. Medical staff will monitor volunteers for 13 months. For more information and to register, visit the link here.
Additional Resources
If you’re exploring more about home insemination topics, you can also check out this dance workout post or learn from the experts at Make a Mom regarding home insemination kits. Another valuable resource is Johns Hopkins Medicine for insights into fertility and related services.
Summary
Moderna is facing recruitment challenges for its COVID-19 vaccine trial targeting adolescents, with only a fraction of the needed volunteers signing up. The urgency is underscored by the pandemic’s toll on children’s health and well-being. Parents can find more information on participation and related topics through various resources.